"Papanicolaou Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytological preparation of cells collected from a mucosal surface and stained with Papanicolaou stain.
| Descriptor ID |
D065006
|
| MeSH Number(s) |
E01.370.225.500.384.100.422 E01.370.225.998.054.422 E04.074.422 E05.200.500.384.100.422 E05.200.998.054.422 E05.242.384.100.422
|
| Concept/Terms |
Papanicolaou Test- Papanicolaou Test
- Test, Papanicolaou
- Pap Test
- Test, Pap
- Pap Smear
- Smear, Pap
- Papanicolaou Smear
- Smear, Papanicolaou
|
Below are MeSH descriptors whose meaning is more general than "Papanicolaou Test".
Below are MeSH descriptors whose meaning is more specific than "Papanicolaou Test".
This graph shows the total number of publications written about "Papanicolaou Test" by people in this website by year, and whether "Papanicolaou Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 2 | 2 |
| 2017 | 5 | 10 | 15 |
| 2018 | 6 | 5 | 11 |
| 2019 | 1 | 2 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Papanicolaou Test" by people in Profiles.
-
SARS-CoV-2 RNA may rarely be present in a uterine cervix LBC sample at the asymptomatic early stage of COVID 19 disease. Cytopathology. 2021 11; 32(6):766-770.
-
Experiences in Electronic Consultation (eConsult) Service in Gynecology from a Quaternary Academic Medical Center. J Med Syst. 2021 Apr 06; 45(5):58.
-
Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncol. 2021 03 01; 7(3):458-460.
-
Cervical Cancer Screening-Past, Present, and Future. Cancer Epidemiol Biomarkers Prev. 2021 03; 30(3):432-434.
-
Cervical pap smears and pandemics: The effect of COVID-19 on screening uptake & opportunities to improve. Womens Health (Lond). 2021 Jan-Dec; 17:17455065211017070.
-
Cancer diagnosis and treatment in the COVID-19 era. Eur J Cancer Care (Engl). 2020 05; 29(3):e13265.
-
Cytology in the time of coronavirus disease (COVID-19): an Italian perspective. J Clin Pathol. 2021 Apr; 74(4):261-263.
-
Modelling risk assessment for cervical cancer in symptomatic Saudi women. Saudi Med J. 2019 May; 40(5):447-451.
-
Pap tests for cervical cancer screening test and contraception: analysis of data from the CONSTANCES cohort study. BMC Cancer. 2019 Apr 05; 19(1):317.
-
Communicating Cervical Cancer Screening Results in Light of New Guidelines: Clinical Practices at Federally Qualified Health Centers. Health Commun. 2020 06; 35(7):815-821.